For example, Tumor Necrosis Factor alpha (TNF-α) inhibitors have been used as a successful therapy for a fraction of IBD patients; however, the majority of recipients either have no response or exhibit a waning response over the course of treatment [7]. The gene discussed is TNF; the disease is inflammatory bowel disease.